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role of IE63 in the regulation of HSV-1 gene expression. Stimulation of gene expression correlates with the ability of IE63 to enhance pre-mRNA 3'-processing at certain poly(A) sites (McLauchlan et aL, 1989 (McLauchlan et aL, , 1992 Sandri-Goldin & Mendoza, 1992) . This is shown primarily by weak, late HSV poly(A) sites, whilst the constitutively stronger IE and early poly(A) sites remain unaffected (McGregor et aL, 1996; Uprichard & Knipe, 1996) . The repressor function of IE63 is associated with an inhibition of viral and cellular pre-mRNA splicing both in vitro and in vivo (Hardy & Sandri-Goldin, 1994) . Additionally, IE63 is necessary and sufficient to cause the redistribution of cellular splicing small nuclear ribonuclear proteins (snRNPs) in HSV-1 infected cells and colocalizes with the snRNPs (Phelan et a/., 1993) ; HSV-I infection has little effect on the distribution of cellular polyadenylation factors (McGregor et aI., 1996) .
UV cross-linking experiments examining the protein binding properties of pre-mRNAs containing poly(A) sites demonstrated consistent binding patterns for both mock-infected and HSV-1 infected nuclear extracts (McGregor eta] ., 1996) similar to the RNA binding patterns of cellular polyadenylation factors (Moore et al., 1988) . HSV-1 infected nuclear extracts demonstrated an overall increase in protein-RNA binding, particularly of two proteins, 64 kDa and 46 kDa, the former being identified as the 64 kDa component of cleavage stimulation factor (CstF). The binding pattern observed using extracts infected with the IE63 null mutant, 27-LacZ (Smith et a] ., 1992), is similar to that of mock infected extracts, suggesting that IE63 may enhance the RNA binding or stabilize the interactions of these proteins, although IE63 itself is not one of the predominant RNA binding proteins under these conditions (McGregor eta] ., 1996).
Here, in vitro expressed and purified IE63 protein was added to RNA-protein UV cross-linking assays to determine whether IE63 binds RNA itself, and/or directly acts to stabilize or enhance the binding of other proteins present in nuclear extracts. We show that purified IE63 protein binds to all RNA substrates tested thus far, regardless of the presence of canonical RNA polyadenylation or splicing motifs. Addition of purified IE63 protein to infected or mock infected nuclear extracts prior to UV cross-linking does not enhance their RNA binding capacity. IE63 does not bind RNA when added back to nuclear extracts indicating that the RNA binding activity of IE63 is insufficient to compete with efficient RNA binding proteins in this assay. IE63 was expressed using the T7 bacterial system. The IE63 coding region was excised from plasmid pSG 130 (Hardwicke et al., 1989) , cloned into the vector pAETSc (a modification of pETSc; Studier et al., 1990) and transformed into a self-lysing strain of E. coil, B121-plysS. IE63 was expressed most efficiently when induced with 0'64 mM-IPTG for 2 h at 31 °C.
A purification procedure for IE63 was developed based on 10 litre batches of cells. Following induction, cells were resuspended in 250ml 25 mM-HEPES pH 7"6, lysed by freezing overnight at -72 °C, and pelleted by centrifugation; pellets were resuspended in 10 ml 25 mM-HEPES pH 7"6 ( Fig.  1 , lane 1). IE63 was precipitated with 35 % ammonium sulphate (Fig. 1 , lane 2) and this fraction applied to a 5 ml methylhydrophobicity interaction FPLC column (Bio-Rad), which was eluted with a gradient of 0'75-0 M-(NH4)2SO 4. IE63 protein eluted in eight 1"5 ml fractions at ~ 0"5 M-(NH4)2SO 4 (data not shown), with 25-50% purity as seen by Coomassie staining of SDS-protein gels (Fig. 1, lane 3) . The peak fractions were pooled and diluted 4-fold in HEPES buffer applied to a I ml MonoQ column (Pharmacia) and eluted with a gradient of 0-1 M-NaC1; IE63 eluted at ---0"35 M-NaC1 (data not shown). The final yield of > 90 % pure IE63 protein (Fig. 1, lane 4) was in the region of 1-2 mg per 10 litres.
RNA-protein UV cross-linking experiments were performed according to the method described by Vakalopoulou et al. (1991) . Briefly, [a2plUTP-labeUed RNA precursor (~-, 600 c.p.m.) was mixed with 1-2"5 gg of purified IE63 protein, previously dialysed into binding buffer (60 mM-KC1, 20 mM-HEPES pH 8"0, 1 mM-MgC12, 10% glycerol). The samples were incubated at room temperature for 15 min to allow RNA-protein interactions to form, then UV cross-linked (250 mJ/cm2). RNaseA was added to I mg/ml and samples incubated at 37 °C for 15 min. SDS-PAGE boiling mix was added to each sample and the samples were boiled for 5 min and separated by 10 % SDS-PAGE; radioactivity in gels was visualized by overnight phosphorimage exposure (Molecular Dynamics). To confirm the presence of IE03 Western blots were probed with a polyclonal anti-peptide antibody (gift from H. Marsden, Institute of Virology, Glasgow, UK), and visualized by enhanced chemiluminescence, prior to phosphorimage analysis. When IE63 protein was added to infected and mock infected nuclear extracts prior to UV cross-linking, 20 lag of nuclear extract proteins (in binding buffer) was mixed with 1-2"5 gg IE63 prior to the room temperature incubation.
HSV-1 infected and mock infected nuclear extracts were prepared as described by Lee & Green (1990) , and [a2p]UTPlabelled RNA precursors as described by McLauchlan et al. (1989) . RNA precursors were synthesized containing poly(A) sites from genes representing each of the HSV-1 temporal classes: IE110 (pAII0) and IE63 (pA63) represented the immediate early class; UL23 (pA23), from the thymidine kinase gene, the early class; and UL44 (pA44), from glycoprotein C and UL38 (pA38) from a virion protein component gene, the late class. PCR-amplified sequences from the 3' regions of these genes were cloned separately into pGEM-1 vectors (McGregor et al., 1996) . Precursor mRNA was also synthesized from the Sau5 plasmid (pASauS), which contains two poly(A) sites from IE and late genes in tandem (McLauchlan et at., 1989) ; from pad1, a plasmid containing the tripartite leader of the adenovirus major late transcript with all its associated splice site motifs; from pJD44, which encodes a 445 bp fragment from the coding portion of the HSV-1 UL44 gene; and from pJD15, which contains a 404 bp fragment from exon i of gene UL15; pJD15 and pJD44 contain no recognized RNA processing motifs.
To determine if IE63 binds to RNA, purified protein was used in the RNA binding assays: 2'2 lag of purified IE63 protein in 25 lal of binding buffer was used in each assay. Fig.  2(a, b) demonstrates that IE63 bound to the five RNA precursors tested: JD15, pA23, Adl, pASau5 (Fig. 2a, lanes  1-4 respectively) , and pA44 (Fig. 2 b, Iane C) ; IE63 also bound to the pAll0 precursor (data not shown). IE63 was identified as the protein cross-linked to the various RNA substrates by Western blotting (data not shown). Binding of IE63 protein was equally efficient for each RNA precursor tested, where equal amounts of IE63 protein were added and RNA precursors used generated bands of similar intensity. Therefore, binding was similar for poly(A) site-containing RNAs representing the IE, early and late classes, as well as splice site containing RNAs and precursors which lacked recognized RNA processing motifs. The binding observed is a good reflection of relative affinity under our assay conditions where neither of the components is limiting. Additional binding studies confirmed that IE63 protein expressed using a baculovirus vector also binds RNA using a similar range of precursors, in an identical manner (data not shown).
McGregor ei al. (I996) utilized RNA-protein UV crosslinking assays to compare the relative RNA-protein binding capacities of a number of HSV poly(A) sites with infected and mock infected nuclear extracts. They found an overall increase in protein-RNA binding efficiencies with infected nuclear extracts, compared to mock infected extracts, for which IE63 was required. Since IE63 protein binds directly to RNA we wished to establish if adding purified IE63 protein into these assays in the presence of HSV-1 infected or mock infected nuclear extracts affected the binding patterns : 1' 7 I~g of purified IE63 was added to the binding assays, together with nuclear extracts and control assays were performed in which IE63 was substituted with binding buffer. Four precursors were tested, pASauS, pA44, pA23 and Adl. Controls in which IE63 alone was added to the assays confirmed that IE63 bound RNA with all four precursors (data not shown, except for pA44; Fig. 2 b, lane C). Protein binding was visualized by 10% SDS-PAGE and the presence of IE63 was confirmed by Western blotting. Fig. 2 (b) shows UV cross-linking with the pA44 precursor with both infected and mock infected nuclear extracts. The binding patterns for the pASau5, pA23 and Adl precursors were identical and therefore have not been shown.
For the infected and mock infected nuclear extracts in the absence of IE63, binding patterns as described by McGregor et al. (I996) and Moore et aI. (I98s) were observed, with an increased binding of certain proteins with the infected extract:s, for which IE63 expression was required (see Fig. 2 b, lanes MI and I without IE63 addition). Western blotting confirmed the presence of IE63 in the infected extracts, and in both infected and mock infected extracts following add-back (data not shown). IE63 protein binding was not detected in the presence of other RNA-binding proteins (Fig. 2b) . Western blot analysis demonstrated that the ~ 69 kDa protein, which is upregulated slightly after IE63 addition, is not IE63 itself (data not shown). Addition of IE63 protein to nuclear extracts did not cause any gross changes to the binding patterns, where UV cross-linked proteins were of comparable size to known components of the 3'-processing complex. McGregor et al. (1996) have identified one band as the 64 kDa component of CstF (see arrow, Fig. 2 b) . However IE63 addition results in an apparent decrease in binding of an unidentified 50 kDa protein with both infected and mock infected extracts.
To determine the specificity of IE63 binding, a series of competition binding assays was performed, utilizing [a2p]UTPlabelled and equivalent UTP non-radioactively labelled RNA precursors from the same, or different templates. As increasing amounts of unlabelled precursor are added to a fixed amount of [a2P]UTPJabelled precursor, specific protein-RNA interactions should be competed out by the non-radioactive RNA. Assays were performed by mixing 600 c.p.m, of radiolabelled precursor with increasing amounts of unlabelled RNA, ranging from 0"1-2 gg, prior to addition of 1-7 gg of IE63, to allow competition for binding sites. The UV cross-linked RNAprotein complexes were visualized by 10 % SDS-PAGE. Two RNA precursors were tested, pA38 and pA63, in both homologous and heterologous assays. IE63 protein binds both precursor RNAs (Fig. 3 a, b , lanes C). There was a proportional decrease in the amount of IE63 protein cross-linked to the labelled precursor, as increasing amounts of homologous or heterologous unlabelled probe were added, visible particularly when 2 lag of unlabelled probe was added (Fig. 3 a, b , lanes 1-3). For pAd8 labelled RNA, unlabelted pA38 and pA63 RNAs were used as homologous and heterologous competitors respectively (Fig. 3a) ; for labelled pA63, unlabelled pA63 and pAd8 RNAs were used as homologous and heterologous competitors respectively. RNA binding was competed out equally efficiently with either homologous or heterologous unlabelled RNA. Densitometry studies have shown that for each competition assay, binding efficiency was reduced from I00% to 40-45% when 2 p~g of either homologous or heterologous cold competitor was added. UV cross-linking assays alone were utilized in this study to demonstrate specifically whether IE63 could bind RNA directly. Although this is not an exhaustive study, we surmise that the in vitro RNA binding capacity of IE63 relates in some way to its function in vivo. It has been established that IE63 has several post-transcriptional functions, causing an inhibition of splicing and a reorganization of the splicing snRNPs, with a concomitant increase in 3'-processing levels. Recently, Brown et aI. (1995) have demonstrated that IE63 can stimulate steadystate accumulation and increase the half-life of normally unstable fl-interferon reporter gene mRNAs by binding selectively to their 3'-ends, and McGregor et al. (1996) have shown that IE63 can promote or stabilize binding of protein factors to poly(A) site-containing RNAs. The ability of IE63 to bind RNA, albeit relatively weakly, may form part of its function allowing direct or indirect interaction with RNA and RNA processing factors without competing with them for RNA binding. How IE63 may act to regulate protein-RNA interactions is not understood, but the ability of IE63 to bind RNA may contribute to the range of related and yet distinct functions which have been attributed to this protein.
